You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|
|---|---|
| Published in |
New England Journal of Medicine, September 2019
|
| DOI | 10.1056/nejmoa1911303 |
| Pubmed ID | |
| Authors |
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek, Michael Böhm, Chern-En Chiang, Vijay K Chopra, Rudolf A de Boer, Akshay S Desai, Mirta Diez, Jaroslaw Drozdz, Andrej Dukát, Junbo Ge, Jonathan G Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta E A Ljungman, Béla Merkely, Jose C Nicolau, Eileen O'Meara, Mark C Petrie, Pham N Vinh, Morten Schou, Sergey Tereshchenko, Subodh Verma, Claes Held, David L DeMets, Kieran F Docherty, Pardeep S Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde |
X Demographics
The data shown below were collected from the profiles of 910 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 143 | 16% |
| Spain | 119 | 13% |
| United Kingdom | 80 | 9% |
| Canada | 28 | 3% |
| Mexico | 25 | 3% |
| Colombia | 20 | 2% |
| Japan | 17 | 2% |
| France | 16 | 2% |
| India | 16 | 2% |
| Other | 119 | 13% |
| Unknown | 327 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 623 | 68% |
| Practitioners (doctors, other healthcare professionals) | 135 | 15% |
| Scientists | 120 | 13% |
| Science communicators (journalists, bloggers, editors) | 32 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,435 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1435 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 1433 | 100% |
| Readers by discipline | Count | As % |
|---|---|---|
| Environmental Science | 1 | <1% |
| Medicine and Dentistry | 1 | <1% |
| Unknown | 1433 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 967. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#17,322
of 25,732,188 outputs
Outputs from New England Journal of Medicine
#742
of 32,654 outputs
Outputs of similar age
#318
of 354,817 outputs
Outputs of similar age from New England Journal of Medicine
#20
of 240 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,654 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,817 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 240 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.